Keystone eSymposia Logo

Innovative Vaccine Approaches

June 28-30, 2021 | 9:00AM EDT | 1:00PM UTC | 3:00PM CEST*
*Program is in development and subject to change


The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.

 Free Access to On Demand Content to Scientists from Low-and Middle-Income Countries

Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.

Apply Here

Vaccines have the power to prevent and potentially eradicate a wide range of infectious diseases, representing one of the most effective life-saving measures at our disposal against global health threats. The recent coronavirus pandemic has brought the importance and urgency of vaccine development efforts into sharp focus. Moreover, the vaccinology field is evolving very rapidly, thanks to advances in our understanding of microbiology, immunology and genomics, as well as advances in structural analysis of antigens and antigen-antibody complexes and impacts of variation. Over the years, this field has also experienced an elucidation of mechanisms of immunity and protection, and identification of correlates. However, many questions are still unsolved and innovative approaches are needed to address new vaccine challenges like antimicrobial resistance, emerging infectious diseases, cancer and diseases associated with our aging population. This conference will cover the latest advances and novel approaches towards vaccine development, including:

  1. Novel antigen delivery systems
  2. In vitro and in vivo model systems for vaccine appraisal
  3. The use of human challenge models
  4. The role of ‘systems biology’ in the comprehensive analysis of immune correlates, biomarker identification and safety
  5. Machine-learning approaches to define correlations between antibody repertoires and protection
  6. Strategies for developing low-cost vaccines for economically challenged populations

Together these topics will provide attendees with the new ideas and tools to continue to forge new frontiers in vaccine capabilities.

Apply Here for Free On Demand Access


Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD


Abstract Submission
‣ For Short Talk Consideration: Passed
‣ For ePoster Presentation: Passed
Final ePoster / SciTalk Submission: Passed
Financial Aid Application: Passed

*Abstract submission is required in order to submit an ePoster and/or Scitalk


Program Details

Keynote Speaker

custom image

Rino Rappuoli, PhD
GlaxoSmithKline Vaccines

Speaking at this eSymposia

Galit Alter

MIT and Harvard University, USA

Pamela J. Bjorkman

California Institute of Technology, USA

Catherine A. Blish

Stanford University School of Medicine, USA

Andrea Carfi

Moderna, USA

Christopher Chiu

Imperial College London, UK

Lawrence Corey

Fred Hutchinson Cancer Research Center, USA

Gordon Dougan

University of Cambridge, UK

Stephen Gordon

Liverpool School of Tropical Medicine, UK

Ravi K. Gupta

University of Cambridge, UK

Gagandeep Kang

Christian Medical College/Translational Health Science and Technology Institute, India

Elizabeth Klemm

Wellcome Trust, UK

Florian Krammer

Icahn School of Medicine at Mount Sinai, USA

Nicole Lurie

Coalition for Epidemic Preparedness Innovations - CEPI, USA

Ankur Mutreja

University of Cambridge, UK

Elisa Nemes

University of Cape Town, South Africa

Mariagrazia Pizza

GlaxoSmithKline Vaccines, Italy

Andrew J. Pollard

University of Oxford, UK

Rino Rappuoli

GlaxoSmithKline Vaccines, Italy

Thomas Rudel

University of Würzburg, Germany

Andrew Steer

Murdoch Children's Research Institute, Australia

Caroline E. Wagner

McGill University, Canada

Gavin J. Wright

Wellcome Trust Sanger Institute, UK








Additional Support




Funding for this conference was made possible (in part) by Grant No. 1 R13 AI161938-01 from the National Institute of Allergy and Infectious Diseases. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Media-in-Kind Support









The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.


This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community.  Here, Debbie Johnson, our CEO, explains how we're going to do that.

Donate to Keystone Symposia

Donate to Keystone Symposia